These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19330796)

  • 1. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth.
    Pass C; MacRae VE; Ahmed SF; Farquharson C
    Cell Biochem Funct; 2009 Apr; 27(3):119-27. PubMed ID: 19330796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and linear bone growth: the inhibitory role of SOCS2 on GH/IGF-1 signaling.
    Farquharson C; Ahmed SF
    Pediatr Nephrol; 2013 Apr; 28(4):547-56. PubMed ID: 22886280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased linear bone growth by GH in the absence of SOCS2 is independent of IGF-1.
    Dobie R; Ahmed SF; Staines KA; Pass C; Jasim S; MacRae VE; Farquharson C
    J Cell Physiol; 2015 Nov; 230(11):2796-806. PubMed ID: 25833299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
    Chen Y; Sun D; Krishnamurthy VM; Rabkin R
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bone mass, altered trabecular architecture and modified growth plate organization in the growing skeleton of SOCS2 deficient mice.
    Macrae VE; Horvat S; Pells SC; Dale H; Collinson RS; Pitsillides AA; Ahmed SF; Farquharson C
    J Cell Physiol; 2009 Feb; 218(2):276-84. PubMed ID: 18803233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins.
    Ahmed SF; Farquharson C
    J Endocrinol; 2010 Sep; 206(3):249-59. PubMed ID: 20631046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOCS2 is the critical regulator of GH action in murine growth plate chondrogenesis.
    Pass C; MacRae VE; Huesa C; Faisal Ahmed S; Farquharson C
    J Bone Miner Res; 2012 May; 27(5):1055-66. PubMed ID: 22228213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeking SOCS and sex steroids.
    Waters MJ
    Trends Endocrinol Metab; 2003; 14(4):149-51. PubMed ID: 12714271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo.
    Michaylira CZ; Simmons JG; Ramocki NM; Scull BP; McNaughton KK; Fuller CR; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2006 Sep; 291(3):G472-81. PubMed ID: 16574995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of cytokine signaling 2 (
    Dobie R; MacRae VE; Pass C; Milne EM; Ahmed SF; Farquharson C
    Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29343614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth cartilage expression of growth hormone/insulin-like growth factor I axis in spontaneous and growth hormone induced catch-up growth.
    Brito I; Gil-Peña H; Molinos I; Loredo V; Henriques-Coelho T; Caldas-Afonso A; Santos F
    Growth Horm IGF Res; 2012; 22(3-4):129-33. PubMed ID: 22583947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I.
    Fleenor D; Arumugam R; Freemark M
    Horm Res; 2006; 66(3):101-10. PubMed ID: 16735796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.
    Yakar S; Isaksson O
    Growth Horm IGF Res; 2016 Jun; 28():26-42. PubMed ID: 26432542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growth hormone-insulin-like growth factor-I axis in chronic kidney disease.
    Mak RH; Cheung WW; Roberts CT
    Growth Horm IGF Res; 2008 Feb; 18(1):17-25. PubMed ID: 17826224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise and the growth hormone-insulin-like growth factor axis.
    Frystyk J
    Med Sci Sports Exerc; 2010 Jan; 42(1):58-66. PubMed ID: 20010129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions.
    Rico-Bautista E; Flores-Morales A; Fernández-Pérez L
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):431-9. PubMed ID: 17070092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells.
    Fruchtman S; Simmons JG; Michaylira CZ; Miller ME; Greenhalgh CJ; Ney DM; Lund PK
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G342-50. PubMed ID: 15831713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper airway loading induces growth retardation and change in local chondrocyte IGF-I expression is reversed by stimulation of GH release in juvenile rats.
    Segev Y; Berdugo-Boura N; Porati O; Tarasiuk A
    J Appl Physiol (1985); 2008 Nov; 105(5):1602-9. PubMed ID: 18787088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of GH/IGF axis on bone and cartilage.
    Dixit M; Poudel SB; Yakar S
    Mol Cell Endocrinol; 2021 Jan; 519():111052. PubMed ID: 33068640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.